Vitamin K epoxide reductase (VKORC1) genetic polymorphism is associated to oral anticoagulant overdose.
Quteineh
Lina
L
Verstuyft
Celine
C
Descot
Christelle
C
Dubert
Liliane
L
Robert
Annie
A
Jaillon
Patrice
P
Becquemont
Laurent
L
D000284:Administration, Oral; D000368:Aged; D000483:Alleles; D000925:Anticoagulants / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D016022:Case-Control Studies; D062787:Drug Overdose; D005260:Female; D014644:Genetic Variation; D005838:Genotype; D006470:Hemorrhage / Q000139:chemically induced*; D006801:Humans; D008297:Male; D006899:Mixed Function Oxygenases / Q000235:genetics*; D020641:Polymorphism, Single Nucleotide; D011446:Prospective Studies; D012307:Risk Factors; D013927:Thrombosis / Q000188:drug therapy; D064417:Vitamin K Epoxide Reductases
D000925:Anticoagulants; D006899:Mixed Function Oxygenases; C578523:VKORC1 protein, human; D064417:Vitamin K Epoxide Reductases